Literature DB >> 9611904

Fecal occult blood tests. A cost-effectiveness analysis.

D Gyrd-Hansen1.   

Abstract

A range of fecal occult blood tests are presently on the market and could potentially be used in population screening programs for the detection of colorectal neoplasms. This paper estimates the relative cost-effectiveness of alternative tests and concludes that the unhydrated Hemoccult II is the most cost-effective. However, the incremental costs per life-year of the HemeSelect test and the rehydrated Hemoccult II test are in line with incremental costs observed in breast cancer and cervical cancer programs.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9611904     DOI： 10.1017/s0266462300012265

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN： 0266-4623            Impact factor:   2.188


  2 in total

1.  One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Authors:  Germaine Wong; Richard L Hope; Kirsten Howard; Jeremy R Chapman; Antoni Castells; Simon D Roger; Michael J Bourke; Petra Macaskill; Robin Turner; Gabrielle Williams; Wai Hon Lim; Charmaine E Lok; Fritz Diekmann; Nicholas B Cross; Shaundeep Sen; Richard D M Allen; Steven J Chadban; Carol A Pollock; Allison Tong; Armando Teixeira-Pinto; Jean Y H Yang; Narelle Williams; Eric Hoi Kit Au; Anh Kieu; Laura James; Jonathan C Craig
Journal:  J Am Soc Nephrol       Date:  2019-04-30       Impact factor: 10.121

2.  Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis.

Authors:  Gary M Ginsberg; Stephen S Lim; Jeremy A Lauer; Benjamin P Johns; Cecilia R Sepulveda
Journal:  Cost Eff Resour Alloc       Date:  2010-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.